J Alcover

501 total citations
29 papers, 382 citations indexed

About

J Alcover is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, J Alcover has authored 29 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Rheumatology. Recurrent topics in J Alcover's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Bladder and Urothelial Cancer Treatments (4 papers). J Alcover is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Bladder and Urothelial Cancer Treatments (4 papers). J Alcover collaborates with scholars based in Spain, United States and Iran. J Alcover's co-authors include Xavier Filella, Rafael Molina, Josep M. Augé, Laura Foj, Pedro L. Fernández, David Fuster, Josep Domingo‐Domenech, Berta Ferrer-Rosell, Jeffrey S. Ross and Begoña Mellado and has published in prestigious journals such as British Journal of Cancer, European Urology and European Journal of Cancer.

In The Last Decade

J Alcover

27 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Alcover Spain 10 190 97 91 88 88 29 382
Arturo Mendoza-Valdés Mexico 4 170 0.9× 80 0.8× 59 0.6× 67 0.8× 60 0.7× 9 307
Rikiya Taoka Japan 13 256 1.3× 123 1.3× 182 2.0× 89 1.0× 65 0.7× 64 557
Sean Ong Australia 8 148 0.8× 88 0.9× 159 1.7× 74 0.8× 56 0.6× 18 374
Chuan-Shu Chen Taiwan 12 146 0.8× 141 1.5× 96 1.1× 54 0.6× 78 0.9× 52 339
Danilo Bottero Italy 13 297 1.6× 98 1.0× 121 1.3× 54 0.6× 92 1.0× 25 461
H. S. Levin United States 9 181 1.0× 133 1.4× 107 1.2× 84 1.0× 38 0.4× 15 396
Zhenlei Zha China 11 264 1.4× 88 0.9× 121 1.3× 64 0.7× 93 1.1× 19 423
Shuai Hu China 10 123 0.6× 63 0.6× 77 0.8× 81 0.9× 46 0.5× 18 310
Hiroyuki Tsunemori Japan 12 144 0.8× 129 1.3× 135 1.5× 53 0.6× 51 0.6× 40 420
Rivas del Fresno M Spain 6 85 0.4× 124 1.3× 232 2.5× 89 1.0× 66 0.8× 16 384

Countries citing papers authored by J Alcover

Since Specialization
Citations

This map shows the geographic impact of J Alcover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Alcover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Alcover more than expected).

Fields of papers citing papers by J Alcover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Alcover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Alcover. The network helps show where J Alcover may publish in the future.

Co-authorship network of co-authors of J Alcover

This figure shows the co-authorship network connecting the top 25 collaborators of J Alcover. A scholar is included among the top collaborators of J Alcover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Alcover. J Alcover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alcover, J & Xavier Filella. (2015). Identification of Candidates for Active Surveillance: Should We Change the Current Paradigm?. Clinical Genitourinary Cancer. 13(6). 499–504. 5 indexed citations
2.
Filella, Xavier, Laura Foj, J Alcover, et al.. (2014). The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10μg/L. Clinica Chimica Acta. 436. 303–307. 30 indexed citations
3.
Foj, Laura, Xavier Filella, J Alcover, et al.. (2013). Variability of assay methods for total and free PSA after WHO standardization. Tumor Biology. 35(3). 1867–1873. 18 indexed citations
4.
Garcı́a-Cruz, E., Albert Carrión, J Alcover, et al.. (2012). Perfil hormonal preoperatorio en pacientes sometidos a prostatectomía radical por cáncer de próstata. Actas Urológicas Españolas. 37(5). 280–285. 2 indexed citations
5.
Aldrete, J. Antonio, et al.. (2009). Pain on injection from propofol may be avoided by changing its formulation. Acta Anaesthesiologica Scandinavica. 54(4). 442–446. 7 indexed citations
6.
Filella, Xavier, et al.. (2007). Usefulness of proprostate-specific antigen in the diagnosis of prostate cancer.. PubMed. 27(1B). 607–10. 5 indexed citations
7.
Domingo‐Domenech, Josep, Begoña Mellado, Berta Ferrer-Rosell, et al.. (2005). Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse. British Journal of Cancer. 93(11). 1285–1294. 101 indexed citations
8.
Filella, Xavier, J Alcover, Llorenç Quintó, et al.. (2004). Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms. Urology. 63(6). 1100–1103. 8 indexed citations
9.
Filella, Xavier, et al.. (2004). Antígeno prostático específico y sus fracciones en el diagnóstico del cáncer de próstata. Medicina Clínica. 122(7). 241–244. 1 indexed citations
10.
Filella, Xavier, et al.. (2004). Antígeno prostático específico y sus fracciones en el diagnóstico del cáncer de próstata. Medicina Clínica. 122(7). 241–244. 1 indexed citations
11.
Filella, Xavier, et al.. (2001). Influence of AFP, CEA and PSA on the in vitro Production of Cytokines. Tumor Biology. 22(2). 67–71. 6 indexed citations
12.
Filella, Xavier, et al.. (2000). Usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for transitional cell carcinoma of the bladder.. PubMed. 20(2B). 1169–72. 14 indexed citations
13.
Fuster, David, et al.. (2000). Tratamiento del dolor óseo metastásico con dosis repetidas de Estroncio-89 en pacientes con neoplasia de próstata. Revista Española de Medicina Nuclear. 19(4). 270–274. 12 indexed citations
14.
Filella, Xavier, J Alcover, Rafael Molina, et al.. (1997). Clinical evaluation of free PSA/Total PSA (Prostate-specific Antigen) ratio in the diagnosis of prostate cancer. European Journal of Cancer. 33(8). 1226–1229. 16 indexed citations
15.
Pons, Françesca, Sergi Vidal‐Sicart, Carles Conill, et al.. (1997). Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 24(10). 1210–1214. 60 indexed citations
16.
Serrano, S., et al.. (1996). Bone metaplasia of urothelial mucosa: An unusual biological phenomenon causing kidney stones. Bone. 18(3). 289–291. 9 indexed citations
17.
Filella, Xavier, et al.. (1995). [Role of tissue polypeptide antigen as a marker in bladder cancer].. PubMed. 19(6). 441–4. 1 indexed citations
18.
Alcover, J, et al.. (1995). [Calculi of papillary origin. An undisputed reality].. PubMed. 29(6-7). 351–4. 5 indexed citations
19.
Romero, Juan Manuel, Llúcia Alós, Carme Mallofré, et al.. (1992). Bladder Wash Cytology and Flow Cytometry for the Diagnosis of Transitional Cell Carcinoma of the Urinary Bladder. European Urology. 21(1). 13–15. 3 indexed citations
20.
Álvarez-Vijande, R., et al.. (1991). Urinary Schistosomiasis with Cutaneous Lesions. Urologia Internationalis. 46(1). 85–86. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arturo Mendoza-Valdés Breakdown of academic impact, for papers by Rikiya Taoka Breakdown of academic impact, for papers by Sean Ong Breakdown of academic impact, for papers by Chuan-Shu Chen Breakdown of academic impact, for papers by Danilo Bottero Breakdown of academic impact, for papers by H. S. Levin Breakdown of academic impact, for papers by Zhenlei Zha Breakdown of academic impact, for papers by Shuai Hu Breakdown of academic impact, for papers by Hiroyuki Tsunemori Breakdown of academic impact, for papers by Rivas del Fresno M
Rankless by CCL
2026